National Health Investors (NYSE:NHI) Price Target Raised to $92.00

National Health Investors (NYSE:NHI) had its price objective boosted by Truist Financial from $85.00 to $92.00 in a research note published on Thursday morning,Benzinga reports. They currently have a buy rating on the real estate investment trust’s stock.

A number of other research firms have also recently weighed in on NHI. KeyCorp lifted their price target on National Health Investors from $80.00 to $88.00 and gave the company an “overweight” rating in a report on Thursday, December 4th. Deutsche Bank Aktiengesellschaft lowered National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 price objective for the company. in a report on Tuesday, January 20th. Cantor Fitzgerald set a $85.00 target price on National Health Investors in a research report on Monday, January 5th. National Bank Financial set a $85.00 target price on National Health Investors in a research note on Tuesday, January 20th. Finally, Wells Fargo & Company boosted their price target on National Health Investors from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 25th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $86.86.

National Health Investors Price Performance

Shares of NYSE NHI opened at $85.11 on Thursday. National Health Investors has a 1-year low of $66.41 and a 1-year high of $91.38. The company has a debt-to-equity ratio of 0.76, a current ratio of 6.90 and a quick ratio of 6.90. The business’s fifty day moving average price is $83.44 and its two-hundred day moving average price is $79.39. The firm has a market capitalization of $4.12 billion, a PE ratio of 28.18, a P/E/G ratio of 4.57 and a beta of 0.65.

National Health Investors (NYSE:NHI) last posted its earnings results on Thursday, February 26th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.01). The company had revenue of $105.82 million during the quarter, compared to the consensus estimate of $95.12 million. National Health Investors had a net margin of 37.81% and a return on equity of 9.56%. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.24 earnings per share. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. On average, research analysts expect that National Health Investors will post 4.41 EPS for the current year.

National Health Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Investors of record on Tuesday, March 31st will be issued a dividend of $0.92 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $3.68 annualized dividend and a yield of 4.3%. National Health Investors’s payout ratio is presently 121.85%.

Hedge Funds Weigh In On National Health Investors

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. JPMorgan Chase & Co. raised its stake in shares of National Health Investors by 305.2% in the 2nd quarter. JPMorgan Chase & Co. now owns 1,203,492 shares of the real estate investment trust’s stock worth $84,389,000 after buying an additional 906,479 shares in the last quarter. Norges Bank bought a new position in National Health Investors during the fourth quarter valued at about $55,301,000. M Holdings Securities Inc. bought a new position in National Health Investors during the second quarter valued at about $36,607,000. Freestone Grove Partners LP acquired a new position in National Health Investors during the fourth quarter worth about $21,869,000. Finally, Adage Capital Partners GP L.L.C. acquired a new position in National Health Investors during the fourth quarter worth about $19,856,000. 62.51% of the stock is owned by institutional investors.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.